Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled date : 2022 - 02 - 14 save search
BioXcel Therapeutics Presents Positive Data from Phase 2 Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2022 ASCO Genitourinary Cancers Symposium
Published: 2022-02-14 (Crawled : 23:00) - biospace.com/
BTAI | $2.56 -1.16% -1.17% 240K
|
Health Technology
|
| O: 0.51%
H: 0.83%
C: -1.24%
bxcl701 phase 2 prostate cancer symposium state trial therapeutics cel asco positive cancer
AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Third- and Fourth-Line Renal Cell Carcinoma
Published: 2022-02-14 (Crawled : 23:00) - globenewswire.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.86%
H: 3.97%
C: 3.97%
fotivda renal cel positive phase 3 cell carcinoma
Positive Covid-19 Test
Published: 2022-02-14 (Crawled : 22:00) - taylordevices.com
TAYD | $46.55 -2.43% -2.49% 26K
|
Producer Manufacturing
|
| O: 0.39%
H: 0.98%
C: 0.0%
covid-19 covid test positive
Inventiva reports cash position and revenues for Full-Year 2021
Published: 2022-02-14 (Crawled : 21:00) - inventivapharma.com
IVA | $3.28 1.86% 1.83% 12K
|
Health Technology
|
| O: 1.36%
H: 3.54%
C: 3.54%
report positive
PURA Industrial Hemp Business Positioned To Benefit From Hemp Advancement Act of 2022
Published: 2022-02-14 (Crawled : 15:30) - globenewswire.com
ALKM | $0.0001 100.0% 16M
|
Manufacturing
|
| O: -14.29%
H: 16.67%
C: 0.0%
trial one positive
Therapeutic Solutions International Spin-Off Campbell Neurosciences Announces Positive Preclinical Safety and Efficacy Data Using CampbellCell™ for Treatment of Schizophrenia
Published: 2022-02-14 (Crawled : 13:30) - biospace.com/
TSOI | $0.0007 0.0% 13M
|
Manufacturing
|
| O: -0.82%
H: 4.96%
C: -6.61%
treatment schizophrenia cel preclinical positive pre-clinical
3M Well Positioned for Long-Term Sustainable Growth and Value Creation
Published: 2022-02-14 (Crawled : 13:30) - prnewswire.com
MMM | $91.48 0.57% 0.0% 3M
|
Producer Manufacturing
|
| O: -0.12%
H: 0.15%
C: -0.84%
one growth positive
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed
Published: 2022-02-14 (Crawled : 13:00) - biospace.com/
BCDA | $0.363 -1.39% -1.4% 62K
|
Health Technology
|
| O: 2.02%
H: 0.0%
C: -14.04%
heart cel positive therapy cardiamp designation
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Published: 2022-02-14 (Crawled : 12:30) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -1.89%
H: 1.36%
C: -0.04%
BHVN | News 0 d | $42.16 -4.25% 0.85% 3.7M
|
Health Technology
|
| O: 0.27%
H: 2.86%
C: 1.95%
treatment trial migraine china topline results positive results topline
Aerojet Rocketdyne Positioned to Continue Driving Growth, Profitability and Value Creation
Published: 2022-02-13 (Crawled : 00:00) - globenewswire.com
LMT | $456.09 0.01% 0.0% 710K
|
Electronic Technology
|
| O: 1.91%
H: 0.39%
C: -1.78%
AJRD | $57.99 1.42% 0.0% 0
|
Electronic Technology
|
| O: -2.48%
H: 1.29%
C: -3.2%
one growth positive
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.